Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%

Healthcare

Page 44
  1. Mar 23, 2026 · 17:17 · APS

    Aptose Bio gets Glass, Lewis support for takeover

    Aptose Bio gets Glass, Lewis support for takeover

    01
  2. Mar 23, 2026 · 17:00 · PINK

    Perimeter Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 31st; Provides Corporate Update

    Perimeter Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 31st; Provides Corporate Update

    02
  3. Mar 23, 2026 · 16:26 · EYE

    Rise Nano's Spectraguard classified as exempt device

    Rise Nano's Spectraguard classified as exempt device

    03
  4. Mar 23, 2026 · 15:15 · AGN

    Algernon Health to open brain PET scanning clinic

    Algernon Health to open brain PET scanning clinic

    04
  5. Mar 23, 2026 · 12:49 · BLCO

    Bausch + Lomb releases Elios results

    Bausch + Lomb releases Elios results

    05
  6. Mar 23, 2026 · 08:24 · QNTM

    Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

    Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

    06
  7. Mar 23, 2026 · 07:30 · APS

    Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement

    Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement

    07
  8. Mar 23, 2026 · 07:01 · EYE

    Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology

    Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology

    08
  9. Mar 23, 2026 · 07:00 · AGN

    Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

    Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

    09
  10. Mar 23, 2026 · 04:00 · RKV

    Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer Research Forum

    Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer Research Forum

    10
  11. Mar 20, 2026 · 19:35 · QNTM

    Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

    Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

    11
  12. Mar 20, 2026 · 17:53 · DHT

    DRI Healthcare Trust closes $108.72M debenture offering

    DRI Healthcare Trust closes $108.72M debenture offering

    12
  13. Mar 20, 2026 · 16:59 · WELL

    Well Health supports Ontario primary care record system

    Well Health supports Ontario primary care record system

    13
  14. Mar 20, 2026 · 07:05 · ARCH

    Arch Biopartners Announces St. Michael's Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide

    Arch Biopartners Announces St. Michael's Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide

    14
← Newer Older →